[{"address1": "21 Business Park Drive", "city": "Branford", "state": "CT", "zip": "06405", "country": "United States", "phone": "(203) 646-6446", "website": "https://azitrainc.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Azitra, Inc., an early-stage biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. It develops ATR-12, a genetically modified strain of S. epidermidis, which is in Phase Ib clinical trial for treating Netherton syndrome, a skin disease. The company also develops ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash experienced by cancer patients undergoing epidermal growth factor receptor inhibitor; and ATR-01, an engineered recombinant human filaggrin protein for treating ichthyosis vulgaris, a skin disease. It has a collaboration with Bayer. The company was incorporated in 2014 and is based in Branford, Connecticut.", "fullTimeEmployees": 10, "maxAge": 86400, "priceHint": 4, "previousClose": 0.1424, "open": 0.148, "dayLow": 0.133, "dayHigh": 0.158, "regularMarketPreviousClose": 0.1424, "regularMarketOpen": 0.148, "regularMarketDayLow": 0.133, "regularMarketDayHigh": 0.158, "forwardPE": -0.45399997, "volume": 4495399, "regularMarketVolume": 4495399, "averageVolume": 1889927, "averageVolume10days": 5817960, "averageDailyVolume10Day": 5817960, "bidSize": 1000, "askSize": 800, "marketCap": 3923186, "fiftyTwoWeekLow": 0.131, "fiftyTwoWeekHigh": 4.49, "priceToSalesTrailing12Months": 6.8503337, "fiftyDayAverage": 0.19488, "twoHundredDayAverage": 0.882415, "currency": "USD", "enterpriseValue": 1726528, "floatShares": 16708421, "sharesOutstanding": 28804600, "sharesShort": 56775, "sharesShortPriorMonth": 203481, "sharesShortPreviousMonthDate": 1713139200, "dateShortInterest": 1715731200, "sharesPercentSharesOut": 0.002, "heldPercentInsiders": 0.18876, "heldPercentInstitutions": 0.31325, "shortRatio": 0.05, "shortPercentOfFloat": 0.0027, "impliedSharesOutstanding": 31434300, "bookValue": 0.15, "priceToBook": 0.90799993, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1711843200, "netIncomeToCommon": -12402743, "trailingEps": -0.43, "forwardEps": -0.3, "enterpriseToRevenue": 3.015, "enterpriseToEbitda": -0.194, "52WeekChange": -0.96818715, "SandP52WeekChange": 0.26238096, "exchange": "ASE", "quoteType": "EQUITY", "symbol": "AZTR", "underlyingSymbol": "AZTR", "shortName": "Azitra Inc", "longName": "Azitra, Inc.", "firstTradeDateEpochUtc": 1687267800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "e7445f64-9918-3241-b1f1-a0f95f2c4b08", "messageBoardId": "finmb_404021170", "gmtOffSetMilliseconds": -14400000, "currentPrice": 0.1362, "targetHighPrice": 5.0, "targetLowPrice": 2.0, "targetMeanPrice": 3.5, "targetMedianPrice": 3.5, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 2, "totalCash": 3001158, "totalCashPerShare": 0.104, "ebitda": -8890109, "totalDebt": 804494, "quickRatio": 2.498, "currentRatio": 2.803, "totalRevenue": 572700, "debtToEquity": 18.604, "revenuePerShare": 0.049, "returnOnAssets": -0.96165, "returnOnEquity": -50.59776, "freeCashflow": -5961756, "operatingCashflow": -9078949, "grossMargins": 1.0, "operatingMargins": -15.74846, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-06-24"}]